BEAT vs AIRT vs HSDT vs IDXX vs IRTC

For growth investors, Solana Company (HSDT) is the stronger pick with 1057% revenue growth year-over-year, versus 1.

7% for Air T, Inc. (AIRT). IDEXX Laboratories, Inc. (IDXX) offers the better valuation at 43. 7x trailing P/E (39. 5x forward), making it the more compelling value choice. Analysts rate IDEXX Laboratories, Inc. (IDXX) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, iRhythm Technologies, Inc.

(IRTC) delivered a total return of +56. 1%, compared to -100. 0% for Solana Company (HSDT). Over 10 years, the gap is even starker: IDXX returned +556. 2% versus HSDT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Air T, Inc.

(AIRT) is the lower-risk stock at 0. 05β versus Solana Company's 2. 77β — meaning HSDT is approximately 5601% more volatile than AIRT relative to the S&P 500. On balance sheet safety, IDEXX Laboratories, Inc. (IDXX) carries a lower debt/equity ratio of 67% versus 23% for Air T, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Solana Company (HSDT) is pulling ahead at 1057% versus 1.

7% for Air T, Inc. (AIRT). On earnings-per-share growth, the picture is similar: iRhythm Technologies, Inc. grew EPS 61. 7% year-over-year, compared to 7. 9% for Air T, Inc.. Over a 3-year CAGR, HSDT leads at 97. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

IDEXX Laboratories, Inc.

(IDXX) is the more profitable company, earning 24. 6% net margin versus -679. 6% for Solana Company — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IDXX leads at 31. 6% versus -351. 0% for HSDT. At the gross margin level — before operating expenses — HSDT leads at 91. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for IRTC: 55.

1% to $193. 67.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Air T, Inc.

(AIRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05)). Solana Company (HSDT) carries a higher beta of 2. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AIRT: +32. 1%, HSDT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BEAT (Healthcare) and AIRT (Industrials) and HSDT (Healthcare) and IDXX (Healthcare) and IRTC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BEAT is a small-cap quality compounder stock; AIRT is a small-cap quality compounder stock; HSDT is a small-cap high-growth stock; IDXX is a mid-cap quality compounder stock; IRTC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.